1. Home
  2. ARTV vs NEUE Comparison

ARTV vs NEUE Comparison

Compare ARTV & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTV
  • NEUE
  • Stock Information
  • Founded
  • ARTV 2019
  • NEUE 2015
  • Country
  • ARTV United States
  • NEUE United States
  • Employees
  • ARTV N/A
  • NEUE N/A
  • Industry
  • ARTV
  • NEUE
  • Sector
  • ARTV
  • NEUE
  • Exchange
  • ARTV NYSE
  • NEUE NYSE
  • Market Cap
  • ARTV 61.9M
  • NEUE 57.1M
  • IPO Year
  • ARTV 2024
  • NEUE 2021
  • Fundamental
  • Price
  • ARTV $2.08
  • NEUE $6.77
  • Analyst Decision
  • ARTV Strong Buy
  • NEUE Hold
  • Analyst Count
  • ARTV 7
  • NEUE 1
  • Target Price
  • ARTV $20.00
  • NEUE $7.00
  • AVG Volume (30 Days)
  • ARTV 215.6K
  • NEUE 10.0K
  • Earning Date
  • ARTV 05-08-2025
  • NEUE 05-08-2025
  • Dividend Yield
  • ARTV N/A
  • NEUE N/A
  • EPS Growth
  • ARTV N/A
  • NEUE N/A
  • EPS
  • ARTV N/A
  • NEUE N/A
  • Revenue
  • ARTV N/A
  • NEUE $907,349,000.00
  • Revenue This Year
  • ARTV N/A
  • NEUE $33.99
  • Revenue Next Year
  • ARTV N/A
  • NEUE $5.90
  • P/E Ratio
  • ARTV N/A
  • NEUE N/A
  • Revenue Growth
  • ARTV N/A
  • NEUE N/A
  • 52 Week Low
  • ARTV $1.78
  • NEUE $3.79
  • 52 Week High
  • ARTV $17.31
  • NEUE $7.66
  • Technical
  • Relative Strength Index (RSI)
  • ARTV N/A
  • NEUE 53.29
  • Support Level
  • ARTV N/A
  • NEUE $6.66
  • Resistance Level
  • ARTV N/A
  • NEUE $6.93
  • Average True Range (ATR)
  • ARTV 0.00
  • NEUE 0.22
  • MACD
  • ARTV 0.00
  • NEUE 0.00
  • Stochastic Oscillator
  • ARTV 0.00
  • NEUE 68.91

About ARTV ARTIVA BIOTHERAPEUTICS INC

Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.

Share on Social Networks: